BioNTech SE has grown revenue −45% a year over three years and 43% a year over five. Revenue growth, 3-year annual rate: −45% (Biotechnology median +21%). Revenue growth, 5-year rate: +43%, growth has slowed since the five-year average. Years of annual history on file: 9, FY2017 to FY2025, as filed.

BNTXBioNTech SE

HealthcareUSD

$112.54

$83.8952 weeks$119.34

Is it growing?

Is BNTX growing?

BioNTech SE has grown revenue −45% a year over three years and 43% a year over five.

−45%

Revenue growth, 3-year annual rate · Biotechnology median +21% · shrinking · compounded from fiscal years as filed

Revenue growth, 5-year rate: +43%
Revenue growth, 5-year rate · −45% over three · growth has slowed since the five-year average
Years of annual history on file: 9
Years of annual history on file · FY2017 to FY2025, as filed

Details›